Email alerts
Advanced Search
  • Feb 26, 2013
    Medtronic Gains First FDA Approval to Conduct Early Feasibility Medical Device Study
    Shared Commitment to Innovation Enables Early Study of Novel Native Outflow Tract Transcatheter Pulmonary Valve in Patients with Pulmonary Valve Failure

    MINNEAPOLIS - February 26, 2013 - Medtronic, Inc. (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the...

  • Feb 25, 2013
    FDA Approves Longer Lengths of Medtronic's Resolute Integrity Stent
    New Sizes of Implantable Medical Device Target Long Coronary Lesions Common Among Diabetes Patients

    MINNEAPOLIS -- Feb. 25, 2013 -- Expanding the applicability of its marquee product for the interventional treatment of coronary artery disease in the United States, Medtronic, Inc. (NYSE: MDT)...

  • Feb 25, 2013
    Medtronic CFO Gary Ellis to Speak at Citi Global Healthcare Conference

    MINNEAPOLIS - Feb. 25, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Citi Global Healthcare Conference on...

  • Feb 19, 2013
    Medtronic Reports Third Quarter Earnings
    Revenue of $4.0 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

    MINNEAPOLIS - February 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2013, which ended January 25, 2013. The Company reported...

  • Feb 14, 2013
    Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2013

    MINNEAPOLIS - February 14, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.26 per share of the Company's common stock. The dividend is payable on...

Show 5102550100 per page